ProfessorSamantha Fraser-Bell

Near-infrared Light Photobiomodulation Treatment for RetinalVein Occlusion Macular Oedema NIRVO

A Phase II, Multicenter, Randomized, Single-Masked, Sham-Controlled Study of Safety, Tolerability and Evidence of Activity of Intravitreal APL-2 Therapy in Patients with Geographic Atrophy (GA) - FILLY Owner: Save Sight

A Phase IV randomised clinical trial of laser therapy for peripheral retinal ischaemia combined with intravitreal aflibercept Eylea versus intravitreal aflibercept monotherapy for diabetic macular oedema LADAMO Owner: Save Sight

Phase 4, open-label, non-randomized, prospective study of OZURDEX in the Treatment of Diabetic Macular Oedema - The AUSSIEDEX Study Owner: Save Sight

Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration

A two-year, randomised, double masked, multi-centre, three-arm study, comparing the efficacy and safety of RTH258 versus Aflibercept, in subjects with Neovascular age-related macular degeneration.

Managing neovascular age-related macular degeneration nAMD over 2 years with a Treat and Extend T and E regimen of 2 mg intravitreal aflibercept - a randomized, open-label, active-controlled, parallel-group phase IV/IIIb study ARIES Owner: Save Sight

Randomised control trial of laser therapy for peripheral retinal ischaemia in diabetic macula oedema

Clinical trial of intravitreal injections of dexamethasone vs bevacizumab in diabetic foveal oedema resistant to laser